Op deze pagina vindt u het laatste nieuws uit de wereld van klinisch onderzoek! Voor het nieuwsoverzicht (nieuwsfeed) op deze pagina worden van een aantal organisaties, instanties, bedrijven en personen de RSS feeds gevolgd. De RSS feeds worden elke 5 – 10 minuten ververst en op deze pagina weergegeven. Voor een overzicht van alle nieuwsbronnen, klik hier.
Omdat de plug-in die ik voor deze pagina gebruik niet overweg kan met de RSS feeds van een aantal organisaties, instanties, bedrijven en personen heb ik een alternatieve pagina ingericht om de RSS feeds van deze organisaties, instanties, bedrijven en personen toch weer te kunnen geven. Klik hier om het alternatieve nieuwsoverzicht te raadplegen.
Meer nieuws en actualiteiten:
- Alternatief nieuwsoverzicht
- Archief Nieuwsbrief voor Goede Onderzoekspraktijken
- Uitgelicht & Gespot op internet
Nieuwsfeed
- CDER SBIA On-Demand Learning Library
- Completed PDUFA VII Deliverables
- Split Real Time Application Review (STAR)
- STAR Pilot Program Assessment
- From Lab To Launch: Navigating The Transition To Commercial Readiness
- Registered Outsourcing Facilities
- PREA Non-Compliance Letters
- Winder Laboratories, LLC - 718601 - 01/07/2026
- Chemspec Chemicals Private Limited - 718403 - 12/23/2025
- Purushothaman Damodara Kumaran, M.D. - 721325 - 12/22/2025
- 2025 Drug Safety Communications
- Drug Safety Communications
- Update on FDA’s ongoing evaluation of reports of suicidal thoughts or actions in patients taking a certain type of medicines approved for type 2 diabetes and obesity
- FDA Requests Removal of Suicidal Behavior and Ideation Warning from Glucagon-Like Peptide-1 Receptor Agonist (GLP-1 RA) Medications
- Untitled Letters
- Kweekvlees: uitdagingen én doorbraken op weg naar impact
- Q&A with Advarra’s Client Experience Team Lead Jennifer DeZurik
- Drugs@FDA Data Files
- Hollandbio welcomes NexduX as new member
- The RW Daily: Journal retracts more than 40 papers over peer review, authorship concerns. And Romanian party stands by minister accused of plagiarism.
- Sage journal retracts more than 40 papers over concerns with peer review, author contributions
- Response to the EC Call for Evidence on the Advanced Materials Act
- A Stronger, More Disciplined Future for Emerging Biopharma
- Novel Drug Approvals for 2026
- FDA Approves First Treatment for Children With Menkes Disease
- Recently Issued Guidance Documents
- Clinical Guidances
- GDUFA IV: Fiscal Years 2028 – 2032
- Apetamin — An Illegally Imported Weight Gain, Figure Augmentation Product
- Working (Well) With Patient Advocates: The Sponsor POV
- GDUFA Paid Facilities List
- CDER Leadership Bios
- Generic Drug Facilities, Sites and Organization Lists
- Real-world Evidence Data now also expanded in the Field of Medical Devices
- Could a change of ownership be relevant to GMP?
- ACRO's Doug Peddicord to Retire this Month
- Testing for ethylene glycol, diethylene glycol and methanol – a hot topic during FDA inspections
- The RW Daily: Professor suspended after university finds fishy results in sushi paper. And "Non-Recommended" vs. "Predatory" journals.
- MDCG publishes Guidance on the Surveillance of Medical Devices and IVDs
- Professor suspended after Japanese university finds fishy results in sushi paper
- Cancer protein affects the heart in mice
- Vitamin C protects fish reproductive health
- Gut microbes from primates change brain gene activity in mice
- Eurachem Publishes New Guide on the Fitness for Intended Use of Analytical Equipment and Systems
- FDA Warning Letter: OOS Handling and HPLC Method Validation
- APIC: Update to the Data Integrity FAQs
- New Ph. Eur. Publication Schedule
- New In-Ear EEG Platform Opens Door to Real-World Neurological Data Collection
- FDA Increases Flexibility on Requirements for Cell and Gene Therapies to Advance Innovation
- Cellular & Gene Therapy Products
